Serono is reported to be looking for a buyer or merger partner, according to a report in the Wall Street Journal.
The Swiss biotechnology company had contracted Goldman Sachs to look for potential candidates that are able to meet the likely hefty price tag for Serono - which is currently valued at around $13 billion and is 62% owned by the founding Bertarelli family.
Insider is taking bets. Email him for the odds.
http://pharmagossip.blogspot.com/2005/10/pfizer-and-serono.html
Serono will still have to pay the hefty $704 million settlement for the "Kickback in Cannes" affair, of course.
http://pharmagossip.blogspot.com/2005/10/serono-kickback-in-cannes.html
No comments:
Post a Comment